death Tagged Articles
Panel members had financial ties to Yaz maker
Why are the birth control pills Yaz and Yasmin still on the market when studies show they are more dangerous than other oral contraceptives?
Generic Yaz will include same blood clot warnings
Watson Pharmaceuticals has launched Vestura, a generic version of Bayer’s blockbuster birth control pill Yaz. Like their brand-name counterpart, these pills will also carry a safety announcement on their packaging, warning users that studies suggest the drospirenone-containing pills may put
Manhattan elevator death spurs criminal investigation
NEW YORK CITY — A criminal investigation into the horrific elevator death of Suzanne Hart, a 41-year-old advertising executive with the Manhattan advertising firm Young and Rubicam, is underway.
Virus linked to rare but serious brain infection with MS, Crohn’s drug
Testing positive for anti-JC virus (JCV) antibodies has been identified as a risk factor for developing progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection associated with use of Tysabri (natalizumab) for the treatment of Multiple Sclerosis (MS) or
Emotions overflow at public forum about Gardasil, as vaccine ‘victims’ speak out
What was designed to be a public health information forum about the HPV vaccine turned into an emotional scene as self-described “victims” of the vaccine spoke out about serious side effects linked to the drug. Perhaps the most well known
New warnings on anti-epilepsy drug Keppra
New warnings and precautions have been added to the safety label of the anti-epileptic drug Keppra (levetiracetam), alerting patients to possible adverse reactions ranging from psychiatric problems to serious skin reactions.
Railway company fined and ordered to reinstate injured worker
The U.S. Occupational Safety and Health Administration (OSHA) has ordered Omaha, Nebraska-based Union Pacific Railroad Co. to immediately reinstate an employee in Idaho who was fired after reporting a work-related injury and to pay the employee more than $300,000 in
FDA advisor warns ‘do not use’ Yaz, Yasmin
When Dr. Sidney Wolfe was asked in 2009 by the Food and Drug Administration (FDA) to join the agency’s Risk Management Advisory Committee for a 4-year term, the head of the Washington, DC-based watchdog group Public Citizen took the task
